文献速递前列腺癌

转移性前列腺癌患者临终轨迹:基于人群的研究

The trajectory of patients who die from metastatic prostate cancer: a population-based study.
PubMed 文献 · BJU Int · 2018-11-25

澳大利亚维多利亚州2000-2010年链接数据纳入4436例转移性前列腺癌患者,从首次多日住院追踪至死亡。中位生存仅4个月,下尿路症状常见(50%),48%接受输血,83%临终前一个月至少一项激进临终护理指标,40%未接受医院姑息治疗。

要点

  • 转移性前列腺癌首次多日住院后中位生存仅4个月,需尽早启动姑息治疗规划。
  • 下尿路症状常见(50%),21%接受下尿路手术,48%需输血,症状负担重。
  • 83%临终前一个月至少一项激进临终护理指标,40%未接受医院姑息治疗。

核心结论

  • 半数转移性前列腺癌患者首次多日住院后生存不足4个月,症状负担重且多次住院和操作。
  • 40%患者未接受任何医院姑息治疗,存在改善姑息治疗及时衔接的机会。

研究设计与样本

  • 基于澳大利亚维多利亚州2000-2010年链接的住院出院、急诊就诊和死亡登记数据的人群队列研究。
  • 纳入4436例从首次因转移性前列腺癌多日住院追踪至死亡的患者。

主要发现

  • 患者中位(IQR)生存4(1,12)个月,中位住院3(1,9)次、急诊1(0,2)次、住院35(18,63)天。
  • 下尿路症状常见(50%),21%接受下尿路操作,48%接受血制品输注。
  • 临终前一个月,3685例(83%)至少一项激进临终护理指标,48%有超过一次急性住院,55%住院≥14天。
  • 2657例(60%)接受医院姑息治疗,中位在死亡前30(11,74)天;23%在社区死亡,77%在医院死亡,其中55%死于急性病床。

临床怎么用

  • 对转移性前列腺癌多日住院患者应早期评估姑息治疗需求,及时转介医院姑息治疗服务。
  • 关注下尿路症状和输血需求,优化症状管理以减少反复住院和操作。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe health service use, symptom and survival characteristics in metastatic prostate cancer (mPCa) in order to outline usual care practices and identify future opportunities to improve the quality of care in this patient group. PATIENTS AND METHODS: This population cohort study, conducted in Victoria, Australia, used 10 years (2000-2010) of linked hospital discharge, emergency visit, and death registration data, to track patients from their first inpatient admission with mPCa until death. Descriptive statistics on inpatient health service use, symptoms, procedures, survival, and place of death are presented. RESULTS: In all, 4436 patients survived a median (interquartile range [IQR]) of 4 (1, 12) months from their first multiday admission with mPCa. They had a median (IQR) of 3 (1, 9) admissions, 1 (0, 2) emergency department presentation, and 35 (18, 63) days admitted to hospital. Lower urinary tract symptoms were common (50%), and 21% underwent lower urinary tract procedures, whilst 48% had blood product transfusions. In the last month of life, 3685 (83%) had at least one indicator of aggressive end-of-life care, including 48% with more than one acute hospital admission, and 55% staying ≥14 days. Hospital-based palliative care was accessed by 2657 (60%), occurring a median (IQR) of 30 (11, 74) days before death. In all, 23% died in the community, whilst 77% died in hospital, of whom 55% died in an acute hospital bed. CONCLUSION: Half of all decedents first admitted for a multiday stay with mPCa survived <4 months thereafter. They had a marked symptom burden, underwent multiple procedures and had multiple admissions. In all, 40% of patients did not receive any hospital-based palliative care. Several opportunities exist to improve the timely transition to palliative care services with mPCa. These data form a benchmark against which future improvements to palliative care integration may be measured.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Collins A, Sundararajan V, Millar J, et al. The trajectory of patients who die from metastatic prostate cancer: a population-based study. BJU Int. 2018. PMID: 30371986. doi:10.1111/bju.14593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。